EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Net Income

Annual Net Income:

-$133.81M-$33.65M(-33.60%)
December 31, 2024

Summary

  • As of today, EWTX annual net profit is -$133.81 million, with the most recent change of -$33.65 million (-33.60%) on December 31, 2024.
  • During the last 3 years, EWTX annual net income has fallen by -$91.00 million (-212.55%).
  • EWTX annual net income is now -1278.80% below its all-time high of -$9.71 million, reached on December 31, 2019.

Performance

EWTX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

Quarterly Net Income:

-$40.67M-$4.55M(-12.60%)
September 30, 2025

Summary

  • As of today, EWTX quarterly net profit is -$40.67 million, with the most recent change of -$4.55 million (-12.60%) on September 30, 2025.
  • Over the past year, EWTX quarterly net income has dropped by -$6.54 million (-19.15%).
  • EWTX quarterly net income is now -1176.80% below its all-time high of -$3.19 million, reached on March 31, 2020.

Performance

EWTX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

TTM Net Income:

-$157.24M-$6.54M(-4.34%)
September 30, 2025

Summary

  • As of today, EWTX TTM net profit is -$157.24 million, with the most recent change of -$6.54 million (-4.34%) on September 30, 2025.
  • Over the past year, EWTX TTM net income has dropped by -$32.95 million (-26.51%).
  • EWTX TTM net income is now -4836.92% below its all-time high of -$3.19 million, reached on March 31, 2020.

Performance

EWTX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

EWTX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-33.6%-19.1%-26.5%
3Y3 Years-212.6%-132.4%-158.1%
5Y5 Years-1278.8%--

EWTX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-212.6%at low-132.4%+0.3%-158.1%at low
5Y5-Year-1278.8%at low-928.5%+0.3%-2102.6%at low
All-TimeAll-Time-1278.8%at low-1176.8%+0.3%-4836.9%at low

EWTX Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$40.67M(-12.6%)
-$157.24M(-4.3%)
Jun 2025
-
-$36.12M(+11.5%)
-$150.70M(-3.2%)
Mar 2025
-
-$40.80M(-2.9%)
-$146.09M(-9.2%)
Dec 2024
-$133.81M(-33.6%)
-$39.66M(-16.2%)
-$133.81M(-7.7%)
Sep 2024
-
-$34.13M(-8.4%)
-$124.29M(-7.3%)
Jun 2024
-
-$31.50M(-10.4%)
-$115.88M(-9.5%)
Mar 2024
-
-$28.52M(+5.4%)
-$105.85M(-5.7%)
Dec 2023
-$100.16M(-48.1%)
-$30.14M(-17.2%)
-$100.16M(-12.0%)
Sep 2023
-
-$25.71M(-19.8%)
-$89.44M(-10.1%)
Jun 2023
-
-$21.47M(+6.0%)
-$81.22M(-7.1%)
Mar 2023
-
-$22.84M(-17.6%)
-$75.82M(-12.1%)
DateAnnualQuarterlyTTM
Dec 2022
-$67.64M(-58.0%)
-$19.41M(-11.0%)
-$67.64M(-11.0%)
Sep 2022
-
-$17.50M(-8.9%)
-$60.92M(-8.1%)
Jun 2022
-
-$16.07M(-9.6%)
-$56.37M(-11.3%)
Mar 2022
-
-$14.66M(-15.5%)
-$50.66M(-18.3%)
Dec 2021
-$42.81M(-150.0%)
-$12.70M(+2.0%)
-$42.81M(-42.2%)
Sep 2021
-
-$12.95M(-25.1%)
-$30.12M(-75.4%)
Jun 2021
-
-$10.35M(-51.9%)
-$17.17M(-59.4%)
Mar 2021
-
-$6.82M(-72.4%)
-$10.77M(-50.8%)
Dec 2020
-$17.12M(-76.4%)
-
-
Jun 2020
-
-$3.95M(-24.1%)
-$7.14M(-124.1%)
Mar 2020
-
-$3.19M
-$3.19M
Dec 2019
-$9.71M
-
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual net income year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Edgewise Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. TTM net income year-on-year change?

What is Edgewise Therapeutics, Inc. annual net profit?

The current annual net income of EWTX is -$133.81M

What is the all-time high annual net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual net profit is -$9.71M

What is Edgewise Therapeutics, Inc. annual net income year-on-year change?

Over the past year, EWTX annual net profit has changed by -$33.65M (-33.60%)

What is Edgewise Therapeutics, Inc. quarterly net profit?

The current quarterly net income of EWTX is -$40.67M

What is the all-time high quarterly net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly net profit is -$3.19M

What is Edgewise Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, EWTX quarterly net profit has changed by -$6.54M (-19.15%)

What is Edgewise Therapeutics, Inc. TTM net profit?

The current TTM net income of EWTX is -$157.24M

What is the all-time high TTM net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high TTM net profit is -$3.19M

What is Edgewise Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, EWTX TTM net profit has changed by -$32.95M (-26.51%)
On this page